+ 91-40-4476 3666
vasudha@vasudhapharma.com

Milestones & Recognitions

MILESTONES & RECOGNITIONS

1994 – 95   : Incorporated the company
1997 – 98   : Commenced operations of Unit - I with turnover of INR. 0.02 billion
2003 – 04   : Obtained WHO GMP certification to all the leading APIs of its Unit-I.

CHEMEXCIL (Basic chemicals, pharmaceuticals & cosmetics export promotion Council), Mumbai presented the “First Award“ to the company for 'Outstanding Export Performance' in Drug & Pharmaceuticals panel for the year 2003.
2005 – 06   : Turnover crossed the milestone of INR. 1.00 billion.

Received status of “Star Export House” from office of the Joint Director General of Foreign Trade, Ministry of Commerce & Industry, Govt. of India.

All India Manufacturer’s Organisation, Andhra Pradesh presented Dr. M. Visweswaraya Industrial Award - 2005 to the company for 'Best Export Performance'.

Business Initiative Directions, Madrid, Spain presented the award "World Quality Commitment International Star Award" – Paris 2005 to the company for ‘Total Quality Management’.
2006 – 07   : Upgraded Unit-I to cGMP standards.
2007 – 08   : Commenced operations of the company’s 2nd production facility (Unit II) at Jawaharlal Nehru Pharma City, Visakhapatnam.
2008 – 09   : Turnover crossed another milestone of INR. 2.00 billion.

Obtained WHO GMP certification to all the leading products of its Unit-II.
2010 – 11   : Turnover crossed another milestone of INR. 3.00 billion.

Commenced operations of the company’s 3rd production facility (Unit III) at Jawaharlal Nehru Pharma City, Visakhapatnam.
USFDA approved the Unit-I facility.
Mexican MOH (COFEPRIS) Certified for Unit-I.
KFDA Certified for Unit-I.
KFDA Certified for Unit-II.
2011 – 12   :

Turnover crossed another milestone of INR. 4.00 billion.

Fitch Ratings assigns to Vasudha Pharma Chem Limited.
National Long – term rating of ‟BBB + (Ind)”// outlook ‛stable’ Short term rating of ‟F2 + (Ind)” w.e.f. 30-06-2011.
Obtained WHO-GMP certification to all the leading APIs of Unit III.

2012 – 13   : Successful completion of USFDA 1st surveillance audit for Unit-I.
2013 – 14   : India Ratings & Research Pvt. Ltd. (Fitch group) has upgraded Vasudha Pharma Chem Ltd.’s Long term issuer rating from
‟IND BBB +” to ‟IND A -” / Outlook ‘Stable’.
Short term rating upgraded from ‟IND A2+” to ‟IND A1”
W.e.f. 06-09-2013.

EU-WC received from CDSCO for Unit-I & Unit-II.
2014 – 15   : Turnover crossed another milestone of INR. 5.00 billion.
2015 – 16   : Received status of “Two Star Export House” from office of the Joint Director General of Foreign Trade, Ministry of Commerce & Industry, Govt. of India, which was valid from 28.10.2015 to 27.10.2020.

Successful completion of USFDA and surveillance audit for Unit-I.
Mexican MOH (COFEPRIS) Certified for Unit-I & Unit-II.
2016 – 17   : Turnover crossed another milestone of INR. 6.00 billion.

India Ratings & Research Pvt. Ltd. (Fitch group) has upgraded Vasudha Pharma Chem Ltd.’s Long term rating from ‟IND A -” to ‟IND A” with Outlook ‘Stable’.
Short term rating is affirmed at ‟IND A1”.
W.e.f. 19-12-2016.
PMDA (Japanese Authority) Certified for Unit-I
WHO (COPP) GMP Certificate by CDSCO for Unit-III
2017 – 18   : EDQM Certified for Unit-I
USFDA Certified for Unit-II
USFDA Certified for Unit-III
For Unit-III, ISO EMS 14001:2015BS, OHSAS 18001:2007
2018 – 19   : India Ratings & Research Pvt. Ltd. (Fitch group) has upgraded Vasudha Pharma Chem Ltd.’s Long term rating from ‟IND A -” to ‟IND A” with Outlook ‘Positive’.
Short term rating is affirmed at ‟IND A1”.
W.e.f. 07-05-2019.
Obtained WHO-GMP certification to Unit-IV
Successful completion of USFDA 3rd surveillance audit for Unit-I.
Russian GMP inspected for Unit-I.
Total Revenue crossed another milestone of INR 8.00 billion.